CA2224346A1 - Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a - Google Patents
Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a Download PDFInfo
- Publication number
- CA2224346A1 CA2224346A1 CA002224346A CA2224346A CA2224346A1 CA 2224346 A1 CA2224346 A1 CA 2224346A1 CA 002224346 A CA002224346 A CA 002224346A CA 2224346 A CA2224346 A CA 2224346A CA 2224346 A1 CA2224346 A1 CA 2224346A1
- Authority
- CA
- Canada
- Prior art keywords
- c10aryl
- c12alkyl
- substituted
- group
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1914/95 | 1995-06-29 | ||
CH191495 | 1995-06-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2224346A1 true CA2224346A1 (en) | 1997-01-16 |
Family
ID=4221546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002224346A Abandoned CA2224346A1 (en) | 1995-06-29 | 1996-06-26 | Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0836610A1 (ru) |
JP (1) | JPH11508548A (ru) |
KR (1) | KR19990028543A (ru) |
CN (1) | CN1196731A (ru) |
AU (1) | AU707474B2 (ru) |
BR (1) | BR9609285A (ru) |
CA (1) | CA2224346A1 (ru) |
CZ (1) | CZ419797A3 (ru) |
EA (1) | EA001356B1 (ru) |
HU (1) | HUP9801805A3 (ru) |
IL (1) | IL118740A0 (ru) |
MX (1) | MX9800218A (ru) |
NO (1) | NO976065L (ru) |
NZ (1) | NZ311686A (ru) |
PL (1) | PL324258A1 (ru) |
SI (1) | SI9620099A (ru) |
SK (1) | SK177897A3 (ru) |
TR (1) | TR199701728T1 (ru) |
WO (1) | WO1997001569A1 (ru) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002036587A2 (en) | 2000-11-01 | 2002-05-10 | Cor Therapeutics, Inc. | Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides |
EP1577289A1 (en) * | 2004-03-18 | 2005-09-21 | Revotar Biopharmaceuticals AG | Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders |
JP5209476B2 (ja) | 2005-09-02 | 2013-06-12 | グリコミメティクス, インコーポレイテッド | ヘテロ二官能性全セレクチン阻害剤 |
EP1764093A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel aromatic compounds and their use in medical applications |
EP1764096A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel phloroglucinol derivatives having selectin ligand activity |
EP1764095A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel nitrocatechol derivatives having selectin ligand activity |
JP5298020B2 (ja) * | 2006-10-12 | 2013-09-25 | グリコミメティクス, インコーポレイテッド | ヘキソースおよびn−アセチルヘキソサミンの糖模倣体置換 |
NZ598863A (en) * | 2007-02-09 | 2013-11-29 | Glycomimetics Inc | Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
US8895510B2 (en) | 2008-04-08 | 2014-11-25 | Glycomimetics, Inc. | Pan-selectin inhibitor with enhanced pharmacokinetic activity |
US8921328B2 (en) | 2010-09-14 | 2014-12-30 | Glycomimetics, Inc. | E-selectin antagonists |
ES2655443T7 (es) | 2011-12-22 | 2021-03-22 | Glycomimetics Inc | Compuestos antagonistas de E-selectina |
CA2891514C (en) | 2012-12-07 | 2020-08-25 | Glycomimetics, Inc. | Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells |
CN107108679B (zh) | 2014-12-03 | 2020-10-23 | 糖模拟物有限公司 | E-选择蛋白和cxcr4趋化因子受体的异双官能抑制剂 |
CA3009836A1 (en) | 2016-01-22 | 2017-07-27 | Glycomimetics, Inc. | Glycomimetic inhibitors of pa-il and pa-iil lectins |
WO2017151708A1 (en) | 2016-03-02 | 2017-09-08 | Glycomimetics, Inc. | Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin |
US11433086B2 (en) | 2016-08-08 | 2022-09-06 | Glycomimetics, Inc. | Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4 |
JP7069136B2 (ja) | 2016-10-07 | 2022-05-17 | グリコミメティクス, インコーポレイテッド | 極めて強力な多量体e-セレクチンアンタゴニスト |
JP7272956B2 (ja) | 2017-03-15 | 2023-05-12 | グリコミメティクス, インコーポレイテッド | E-セレクチンアンタゴニストとしてのガラクトピラノシル-シクロヘキシル誘導体 |
US11712446B2 (en) | 2017-11-30 | 2023-08-01 | Glycomimetics, Inc. | Methods of mobilizing marrow infiltrating lymphocytes and uses thereof |
CN111566117A (zh) | 2017-12-29 | 2020-08-21 | 糖模拟物有限公司 | E-选择蛋白和半乳凝素-3的异双功能抑制剂 |
AU2019230013A1 (en) | 2018-03-05 | 2020-09-10 | Glycomimetics, Inc. | Methods for treating acute myeloid leukemia and related conditions |
US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5326752A (en) * | 1991-11-27 | 1994-07-05 | Glycomed Incorporated | Substituted lactose and lactosamine derivatives as cell adhesion inhibitors |
WO1993023031A1 (en) * | 1992-05-08 | 1993-11-25 | The Biomembrane Institute | Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response |
CA2100412A1 (en) * | 1992-07-15 | 1994-01-16 | Yutaka Yamada | Glycolipid derivatives |
-
1996
- 1996-06-26 WO PCT/EP1996/002785 patent/WO1997001569A1/en not_active Application Discontinuation
- 1996-06-26 HU HU9801805A patent/HUP9801805A3/hu unknown
- 1996-06-26 CZ CZ974197A patent/CZ419797A3/cs unknown
- 1996-06-26 EP EP96922034A patent/EP0836610A1/en not_active Ceased
- 1996-06-26 IL IL11874096A patent/IL118740A0/xx unknown
- 1996-06-26 SK SK1778-97A patent/SK177897A3/sk unknown
- 1996-06-26 NZ NZ311686A patent/NZ311686A/xx unknown
- 1996-06-26 JP JP9504171A patent/JPH11508548A/ja active Pending
- 1996-06-26 EA EA199800103A patent/EA001356B1/ru not_active IP Right Cessation
- 1996-06-26 CN CN96196452A patent/CN1196731A/zh active Pending
- 1996-06-26 BR BR9609285A patent/BR9609285A/pt not_active Application Discontinuation
- 1996-06-26 CA CA002224346A patent/CA2224346A1/en not_active Abandoned
- 1996-06-26 TR TR97/01728T patent/TR199701728T1/xx unknown
- 1996-06-26 AU AU63053/96A patent/AU707474B2/en not_active Ceased
- 1996-06-26 PL PL96324258A patent/PL324258A1/xx unknown
- 1996-06-26 KR KR1019970709861A patent/KR19990028543A/ko not_active Application Discontinuation
- 1996-06-26 SI SI9620099A patent/SI9620099A/sl unknown
-
1997
- 1997-12-23 NO NO976065A patent/NO976065L/no not_active Application Discontinuation
-
1998
- 1998-01-07 MX MX9800218A patent/MX9800218A/es unknown
Also Published As
Publication number | Publication date |
---|---|
SK177897A3 (en) | 1998-08-05 |
NO976065D0 (no) | 1997-12-23 |
WO1997001569A1 (en) | 1997-01-16 |
AU707474B2 (en) | 1999-07-08 |
AU6305396A (en) | 1997-01-30 |
TR199701728T1 (xx) | 1998-03-21 |
EA001356B1 (ru) | 2001-02-26 |
BR9609285A (pt) | 1999-05-11 |
EP0836610A1 (en) | 1998-04-22 |
HUP9801805A3 (en) | 2002-01-28 |
HUP9801805A2 (hu) | 1998-12-28 |
SI9620099A (sl) | 1998-08-31 |
CZ419797A3 (cs) | 1998-06-17 |
NZ311686A (en) | 2000-01-28 |
NO976065L (no) | 1998-02-17 |
MX9800218A (es) | 1998-07-31 |
JPH11508548A (ja) | 1999-07-27 |
KR19990028543A (ko) | 1999-04-15 |
EA199800103A1 (ru) | 1998-08-27 |
PL324258A1 (en) | 1998-05-11 |
IL118740A0 (en) | 1996-10-16 |
CN1196731A (zh) | 1998-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2224346A1 (en) | Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a | |
CA2260854A1 (en) | Modified oligosaccharides | |
US4058519A (en) | Adriamycins and uses thereof | |
US4039663A (en) | Daunomycins, process for their uses and intermediates | |
JPS6129359B2 (ru) | ||
EP0491960B1 (en) | Alkylated oligosaccharide and acetyl derivative thereof | |
EP0549040A1 (en) | Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A | |
Alvarez-Mico et al. | A new glycosidation method through nitrite displacement on substituted nitrobenzenes | |
CA1257257A (en) | Sialic acid derivative and process for preparing the same | |
JPH09132585A (ja) | 新規アミノ糖及びキトオリゴ糖又はその類似オリゴ糖の製造方法 | |
DE60124245T2 (de) | Uridinderivate als antibiotika | |
KR101529061B1 (ko) | 당류 구조물, 그리고 이러한 구조물의 제조 및 사용 방법 | |
JPH0592987A (ja) | 4′−デメチルエピポドフイロトキシングリコシド類 | |
JPWO2004067544A1 (ja) | 新規化合物カプラゼンとカプラゼン誘導体、ならびに新規化合物カプラゾールとカプラゾール誘導体 | |
CN1063183C (zh) | 杂环基、糖基多取代的三唑类化合物及其合成方法 | |
KR920001690B1 (ko) | 니트로소우레아 유도체의 제조방법 | |
JPH0560474B2 (ru) | ||
DE3641835A1 (de) | Zytostatisch wirksame anthracyclinderivate | |
US5358937A (en) | Glycosyl phospholipid derivatives of nucleosides and their use as medicines | |
KR0133726B1 (ko) | 신규 안트라사이클린 글리코사이드 유도체 | |
Pískala et al. | Synthesis of N 4-Alkyl-5-azacytidines and Their Base-Pairing with Carbamoylguanidines-A Contribution to Explanation of the Mutagenicity of 2'-Deoxy-5-azacytidine | |
JP4071416B2 (ja) | シアル酸分岐シクロデキストリン誘導体とその中間体 | |
HU186383B (en) | Process for producing new citostatic amni-acridie-alpha, beta-bracket-d-bracket closed, or aracket-l-bracket closed-n-glycoside derivatives and salts | |
US5338728A (en) | Pradimicin compounds | |
JPS5833880B2 (ja) | ダウノマイシンルイノセイホウ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |